EPREmergency Preparedness & Response
- Specific Hazards
- Bioterrorism
- A–Z
- Anthrax
- Arenaviruses
- Botulism
- Brucella
- Cholera
- Ebola virus
- E. coli
- Food safety threats
- Glanders
- Lassa fever
- Marburg virus
- Melioidosis
- Plague
- Q fever
- Salmonella
- Shigella
- Smallpox
- Smallpox Basics
- Vaccine Basics
- Clinicians
- Vaccination Q & A (for professionals)
- Health Officials
- People Selected for Response Teams
- Diagnosis/
Evaluation - Lab Testing
- Infection Control
- Surveillance & Investigation
- Preparation & Planning
- Response
- Vaccination
- Images
- Medical Management
- Training & Education
- References
- Tularemia
- Typhoid fever
- Viral hemorrhagic fevers
- List by Category
- Fact Sheets
- Case Definitions
- Training
- Surveillance
- Preparation & Planning
- First Responders
- Lab Info
- A–Z
- Chemical
- A–Z
- Abrin
- Adamsite
- Ammonia
- Arsenic
- Arsine
- Barium
- Benzene
- Brevetoxin
- Bromine
- BZ
- Carbon monoxide
- Chlorine
- Chromium
- Colchicine
- Cyanide
- Digitalis
- Ethylene glycol
- Hydrazine
- Hydrofluoric acid
- Lewisite
- Melamine
- Mercury
- Methyl bromide
- Methyl isocyanate
- Nicotine
- Nitrogen mustard
- Opioids
- Organic solvents
- Osmium tetroxide
- Paraquat
- Phosgene
- Phosgene oxime
- Phosphine
- Phosphorus
- Pulmonary agents
- Ricin
- Sarin
- Saxitoxin
- Selenium
- Sodium azide
- Sodium monofluoroacetate
- Soman
- Strychnine
- Sulfur mustard
- Sulfuryl Fluoride
- Super Warfarin
- Tabun
- Tetrodotoxin
- Thallium
- Trichothecene
- Unidentified Chemical
- VX
- List by Category
- Chemical-Specific Fact Sheets
- Toxicology FAQs
- Case Definitions
- Toxic Syndrome Descriptions
- Toxicological Profiles
- Training
- First Responders
- Medical Management
- Emergency Response Cards
- Lab Info
- Surveillance
- Preparation & Planning
- A–Z
- Radiation
- Mass Casualties
- Natural Disasters & Severe Weather
- Recent Outbreaks & Incidents
- Bioterrorism
- Preparedness for All Hazards
- What CDC Is Doing
- What You Can Do
- What's New
Anthrax: Laboratory Testing
Specimen Collection & Shipping
- Acceptable Biological Specimens Needed for Testing for Anthrax
Feb 2006 - Inhalation Anthrax: Recommended Specimens for Microbiology & Pathology for Diagnosis
Feb 2006 - Cutaneous Anthrax: Recommended Specimens for Microbiology & Pathology for Diagnosis
Feb 2006 - Collecting, Preparing, & Shipping Serum Samples to CDC for Serology Testing
Feb 2006 - Comprehensive Procedures for Collecting Environmental Samples for Culturing Bacillus anthracis
Apr 26, 2002
Lab Procedures & Protocols
- Q & A: Laboratory Testing
For the public. Effectiveness, home test kits, getting screened, Mayo Clinic/Roche Rapid Anthrax test...
Jun 2, 2003 -
Q & A: Laboratory Safety
Keeping lab workers safe...
Jun 2, 2003 - Algorithm for Laboratory Diagnosis of Anthrax
Feb 2006 - Basic Diagnostic Testing Protocols for Level A Laboratories for the Presumptive Identification of Bacillus anthracis (413 KB/18 pages)
NOTE: Protocols for sentinel laboratories are no longer posted on the CDC website. The American Society for Microbiology has agreed to take the lead in the development & dissemination of sentinel laboratory information. Information for reference laboratories will continue to be available on the Laboratory Response Network secure website (for questions, e-mail lrn@cdc.gov; tollfree HelpDesk 1-866-LRN-LABS [1-866-576-5227]). The CDC subject matter experts on individual organisms remain available for discussion as always.
Mar 18, 2002 - Approved Tests for the Detection of Bacillus anthracis in the U.S. Laboratory Response Network
Jan 28, 2001
Historical Archives: 2001 Outbreak & Other Incidents
-
Laboratory Response to Anthrax Bioterrorism, New York City, 2001
Emerging Infectious Diseases 2002 Oct;8(10):1096-1102. -
Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak in the United States
Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID)
Alex Hoffmaster, CDC, Atlanta, GA
Mar 26, 2002 -
Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax OutbreakOctoberDecember, 2001
Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID)
Carolyn Greene, CDC, Atlanta, GA
Mar 26, 2002
Additional Research & References
- Ruling Out Bacillus anthracis
Emerging Infectious Diseases 2004 Apr;10(4): 732-735 - Nonhemolytic, Nonmotile Gram-Positive Rods Indicative of Bacillus anthracis
Emerging Infectious Diseases 2003 Aug;9(8):1013-1015. - Molecular Subtyping of Bacillus anthracis & the 2001 Bioterrorism-Associated Anthrax Outbreak, United States
Emerging Infectious Diseases 2002 Oct;8(10):1111-1116. - Specific, Sensitive, & Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen
Emerging Infectious Diseases 2002 Oct;8(10):1103-1110. - A Two-Component Direct Fluorescent-Antibody Assay for Rapid Identification of Bacillus anthracis
Emerging Infectious Diseases 2002 Oct;8(10):1060-1065. - Sequencing of 16S rRNA Gene: A Rapid Tool for Identification of Bacillus anthracis
Emerging Infectious Diseases 2002 Oct;8(10):1117-1123. - Recognition of Illness Associated with the Intentional Release of a Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
PDF (168 KB/20 pages)
- Share
- Add this to...
- Favorites
- Del.icio.us
- Digg
- Google Bookmarks
- Technorati
- Yahoo MyWeb
- Updates
- Subscribe
- Listen
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov